| Price | 4.80p on 20-05-2026 at 17:45:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 4.90p |
| Sell | 4.70p |
| Last Trade: | Buy 41,493.00 at 4.82p |
| Day's Volume: | 748,195 |
| Last Close: | 4.80p |
| Open: | 4.80p |
| ISIN: | GB00BKPG7Z60 |
| Day's Range | 4.80p - 4.90p |
| 52wk Range: | 2.40p - 5.18p |
| Market Capitalisation: | £33.84m |
| VWAP: | 4.800865p |
| Shares in Issue: | 705.10m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Poolbeg Pharma (POLB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 41,493 | 4.82p | Ordinary |
16:24:17 - 20-May-26 |
| Buy* | 209 | 4.898p | Ordinary |
16:05:45 - 20-May-26 |
| Buy* | 9,000 | 4.82p | Ordinary |
15:33:08 - 20-May-26 |
| Sell* | 9,816 | 4.70p | Ordinary |
14:51:27 - 20-May-26 |
| Buy* | 20,614 | 4.82p | Ordinary |
14:42:57 - 20-May-26 |
| Buy* | 2 | 4.90p | Suspected BUY Trade |
14:00:28 - 20-May-26 |
| Buy* | 204 | 4.898p | Ordinary |
13:38:13 - 20-May-26 |
| Buy* | 20,726 | 4.8248p | Ordinary |
12:50:37 - 20-May-26 |
| Buy* | 103,541 | 4.829p | Ordinary |
12:43:47 - 20-May-26 |
| Sell* | 220,000 | 4.7375p | Ordinary |
12:34:48 - 20-May-26 |
Poolbeg Pharma (POLB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th May 2026 7:00 am | RNS | POLB 001 poster to be presented at EHA 2026 |
| 11th May 2026 7:00 am | RNS | POLB 001 CRS patent granted in Canada |
| 7th May 2026 7:00 am | RNS | Annual Report & AGM Notice |
| 28th Apr 2026 7:00 am | RNS | Results for the year ended 31 December 2025 |
| 15th Apr 2026 7:00 am | RNS | MHRA grants CTA for the POLB 001 TOPICAL trial |
| 31st Mar 2026 7:00 am | RNS | Significant milestone for Poolbeg's IP portfolio |
| 12th Mar 2026 7:00 am | RNS-R | Appointment of Dr Adrian Kilcoyne to SAB |
| 9th Feb 2026 3:13 pm | RNS | Notification of Major Holdings |
| 28th Jan 2026 7:00 am | RNS | POLB 001 LPS Challenge Trial Paper Published |
| 27th Jan 2026 2:30 pm | RNS | Exercise of Options & Total Voting Rights |
